Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Sterling Pharmaceuticals
Sterling Pharmaceuticals
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
AstraZeneca's Tagrisso obtains FDA approval for use in stage III NSCLC
Tagrisso reduced the risk of disease progression or death by 84% compared to placebo in the Phase III LAURA trial
Samsung Biologics debuts a series of monoclonal antibody development platforms
These solutions aim to optimise the efficacy of monoclonal antibody therapies, while also minimising the presence of charged variants
Flagship Pioneering launches gene therapy-focused biotech, Mirai Bio with $50m investment
The biotech has a machine intelligence-based open platform that aims to optimise a gene therapy's credentials, while also boosting the likelihood of its commercialisation
Quell and eXmoor join forces to manufacture and scale CAR-Treg therapies
The companies will combine their expertise to manufacture CAR-Treg cell therapies for clinical trials, with protocols put in place to support their scaling
Lonza to manufacture Vertex's CRISPR/Cas9 cell therapy, Casgevy
The one-time treatment will benefit patients with transfusion-dependent beta-thalassemia or sickle cell disease
Upcoming event
ISCC
15-18 October 2024 | Conference | Milan, Italy
See all
Related Content
Analysis
Sterling Pharma Solutions bolsters UK bioanalytical capabilities
The expansion includes a novel laboratory space for the ADC analytical services team, which enhances the company's offering to those developing biologics
Manufacturing
Sterling Pharma Solutions expands US ADC development and manufacturing capabilities
The CDMO will install a modular isolator to support clinical and commercial production of ADC’s
Recruitment
Vacancy at Sterling Pharmaceuticals: Maintenance Engineer
Recruitment
Vacancy at Sterling Pharmaceuticals: Analytical Chemist (R and D)
Subscribe now